Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04789317
Other study ID # CRI050
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 23, 2020
Est. completion date December 31, 2025

Study information

Verified date March 2021
Source VZW Cardiovascular Research Center Aalst
Contact Carlos Collet, MD PhD
Phone 003253721927
Email carloscollet@gmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to determine the predictive capacity of the Pullback Pressure Gradient (PPG) index for post-PCI FFR and to determine the impact of the PPG index on clinical decision making about revascularization and on clinical outcomes.


Description:

A Fractional Flow Reserve (FFR) evaluation comprises measurement of a distal single value and a pullback maneuver during hyperemic conditions. The PPGindex is a novel metric derived from the FFR pullback curve.3 This metric complements the distal FFR value by informing the spatial distribution of epicardial resistance (i.e. focal or diffuse) along the coronary vessel. The PPGindex relies on two components: first, the magnitude of pressure drop determined as a maximal pressure gradient over 20 millimeters relative to the total vessel gradient; and second, the length of functional disease relative to total vessel length. These two parameters are weighted equally to provide a metric that ranges from 0 to 1. PPGindex values approaching 1 represent functional focal coronary artery disease (CAD) whereas values close to 0 represent diffuse functional CAD. Until now, the interpretation of the FFR pullback relied on visual assessment. The PPGindex quantifies the pattern of functional CAD and has been shown to predict functionally complete revascularization. Percutaneous revascularization in vessels with high PPGindex is associated with high post-PCI FFR and vast improvement in epicardial conductance whilst PCI in vessels with low PPGindex results in low post-PCI FFR. An curvilinear relationship is observed between PPGindex and functional gain (i.e. FFR post-PCI minus FFR pre-PCI). The PPGindex, therefore, aims to predict the response to PCI in physiological terms. Calculation of the PPGindex is indicated in cases with an FFR≤0.80. FFR pullbacks are performed under hyperemic conditions at a steady pace during manual pullback. A calculation of the PPGindex using the Coroflow console (Coroventis Research Ab, Uppsala, Sweden) is available for online use and computes the PPG value immediately after the pullback maneuver. This software also includes an automated drift correction. The pullback curve is depicted on an dedicated pullback display screen and the pressure gradients are shown per millimeter, allowing correlation between the location of pressure step-ups and the anatomical target for PCI. In summary, we can distinguish three points where FFR influences the clinical decision-making process. First, an FFR ≤0.80 indicates potential benefit of revascularization. Second, the pullback curve assesses disease pattern and PPG index value quantifies it, helping de physician in the decision about treatment options (e.g. PCI, CABG or OMT). And, third, the location of pressure step-ups along the vessels helps plan the PCI strategy with respect to coverage of functional disease. A combined FFR and PPG-guided PCI strategy has the potential to improve patient selection and enhance procedural planning. The purpose of this study is to determine the predictive capacity of the PPG index for post-PCI FFR and to determine the impact of the PPG index on clinical decision making about revascularization and on clinical outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 982
Est. completion date December 31, 2025
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Consecutive patients with stable coronary artery disease or stabilized acute coronary syndrome and invasive FFR measurement =0.80. Exclusion Criteria: - Angiographic exclusion criteria 1. Ostial lesions. 2. Severe vessel tortuosity. 3. Vessel rewiring deemed 'difficult' by the operator. 4. Bifurcation with planned two-stent strategy. 5. NSTEMI culprit vessel. 6. STEMI 7. Uncontrolled or recurrent ventricular tachycardia. 8. Hemodynamic instability 9. Severe renal dysfunction, defined as an eGFR <30 mL/min/1.73 m2

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Australia Monash Medical Center Melbourne Clayton VIC
Belgium OLV-Aalst Aalst Oost-Vlaanderen
Italy Centro Cardiologico Monzino Milan
Japan Showa University Hospital Shinagawa Tokyo
United Kingdom University of Glasgow Glasgow
United Kingdom King's College London London
United States Memorial Hermann Texas Medical Center Texas City Texas

Sponsors (1)

Lead Sponsor Collaborator
VZW Cardiovascular Research Center Aalst

Countries where clinical trial is conducted

United States,  Australia,  Belgium,  Italy,  Japan,  United Kingdom, 

References & Publications (1)

Collet C, Sonck J, Vandeloo B, Mizukami T, Roosens B, Lochy S, Argacha JF, Schoors D, Colaiori I, Di Gioia G, Kodeboina M, Suzuki H, Van 't Veer M, Bartunek J, Barbato E, Cosyns B, De Bruyne B. Measurement of Hyperemic Pullback Pressure Gradients to Characterize Patterns of Coronary Atherosclerosis. J Am Coll Cardiol. 2019 Oct 8;74(14):1772-1784. doi: 10.1016/j.jacc.2019.07.072. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Rate of patients with intended PCI but deferred after PPG calculation. Assess the influence of pullback and PPG on identification of patterns of CAD and change in treatment strategy 1 year
Primary Predictive capacity of the PPG index for post-PCI FFR. Describe the relationship between pre PCI PPG and post-PCI FFR 1 year
Secondary To assess the relationship between baseline PPG index and major adverse cardiovascular events (cardiac death, peri-procedural and spontaneous myocardial infarction and target vessel revascularization) at one, two and three years. Assess whether the PPG and identification of CAD endo-type has a relationship with per and post-procedure events 3 years after completion of inclusion
Secondary Difference between baseline and 12 month follow-up in the Seattle Angina Questionnaire (SAQ) stratified by PPG index. Assess the relationship with symptoms assessed by the SAQ and PPG and persistent/recurrent angina post-PCI 1 years after completion of inclusion
See also
  Status Clinical Trial Phase
Recruiting NCT05056662 - Post-Revascularization Optimization and PHysiological Evaluation of intermediaTe Lesions
Terminated NCT01833338 - Non-invasive and Invasive Plaque Characterisation N/A
Recruiting NCT06323811 - Comparison of Free-breathing 3D Quantitative Perfusion in Patients With MINOCA and MINOCA-mimics N/A
Recruiting NCT02402400 - Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome/Non ST-elevation Myocardial Infarction - A Platelet Reactivity Study Phase 4
Completed NCT01863134 - Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up Phase 4
Active, not recruiting NCT01687686 - Differential Effects of Lipids on Cardiovascular Diseases: A CALIBER Study N/A
Not yet recruiting NCT02032303 - Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor . Phase 4
Not yet recruiting NCT02032290 - Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel Phase 4
Completed NCT04887571 - the PrEsentation, Rationale and Impact of reperFUSION for Acute Coronary Syndromes in Cape Town and the Garden Route Health District - the PERFUSION Registry
Active, not recruiting NCT03048825 - Colchicine and Spironolactone in Patients With MI / SYNERGY Stent Registry Phase 3
Recruiting NCT05182970 - Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET) Phase 3
Completed NCT05409716 - Compressive Elastic Dressing Versus TR Band N/A
Withdrawn NCT02893280 - Acute Coronary Syndrome Sri Lanka Audit Project N/A
Completed NCT01895751 - Conservative Non-Invasive Versus Routine Invasive Management in Coronary Artery Bypass Surgery Patients With Non ST Elevation Elevation Acute Coronary Syndrome Phase 4